KeyBank National Association
CBAY

KeyBank National Association’s Cymabay Therapeutics CBAY Stock Holding History

KeyBank National Association’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,997
Closed -$283K – 1131
2023
Q4 		$283K Buy
+11,997
New +$214K ﹤0.01% 943

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

KeyBank National Association's CBAY Position: Q1 2024 in Review

KeyBank National Association sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 11,997 shares — an estimated $283K sold.

KeyBank National Association first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $283K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • KeyBank National Association reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • KeyBank National Association sold 11,997 Cymabay Therapeutics shares in Q1 2024, an estimated $283K.
  • KeyBank National Association first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
  • KeyBank National Association's Cymabay Therapeutics position peaked at $283K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on KeyBank National Association's 13F filing for Q1 2024, filed 14 May 2024.